Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Dapt Study Investigators"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antonio Colombo, Lorenz Räber, Hyo-Soo Kim, Marco Valgimigli, Thomas Pilgrim, Myeong Ki Hong, Stephan Windecker, Francesco Costa, Fausto Feres, Ewout W. Steyerberg, Precise-Dapt Study Investigators, David van Klaveren
Publikováno v:
American Heart Journal, 223, 44-47. Mosby Inc.
The originally-proposed PRECISE-DAPT score is a 5-item risk score supporting decision-making for dual antiplatelet therapy1 duration after PCI. It is unknown if a simplified version of the score based on 4 factors (age, hemoglobin, creatinine clearan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d3e9060c68cc01b09872cae883d2a96
https://pubmed.ncbi.nlm.nih.gov/32151822
https://pubmed.ncbi.nlm.nih.gov/32151822
Autor:
Joseph M. Massaro, Wen-Hua Hsieh, Philippe Gabriel Steg, Robert W. Yeh, Donald E. Cutlip, Jean-François Tanguay, Laura Mauri, Dapt Study Investigators, Dean J. Kereiakes, Ada C. Stefanescu Schmidt
Publikováno v:
The American journal of cardiology. 124(12)
The risk of major adverse cardiac and cerebrovascular events (MACCE) in subjects who interrupt temporarily or permanently thienopyridine therapy in the first 6 months after percutaneous coronary intervention (PCI) remains uncertain. In the dual antip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8200d4d964c6bddcedf9a2cedf7f968
https://pubmed.ncbi.nlm.nih.gov/31653353
https://pubmed.ncbi.nlm.nih.gov/31653353
Autor:
Stefan James, Precise-Dapt Study Investigators, Gregg W. Stone, Ewout W. Steyerberg, Lorenz Räber, Fausto Feres, Antonio Colombo, Myeong Ki Hong, Francesco Costa, Marco Valgimigli, Hyo-Soo Kim, David van Klaveren, Thomas Pilgrim, Deepak L. Bhatt, Stephan Windecker, Philippe Gabriel Steg
Publikováno v:
Journal of the American College of Cardiology, 73(7), 741-754
Background Complex percutaneous coronary intervention (PCI) is associated with higher ischemic risk, which can be mitigated by long-term dual antiplatelet therapy (DAPT). However, concomitant high bleeding risk (HBR) may be present, making it unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d390decb0b79ecbe907cb9650f4f9b2
https://hdl.handle.net/1887/121100
https://hdl.handle.net/1887/121100
Autor:
Dapt Study Investigators, Dean J. Kereiakes, Robert W. Yeh, Stephen D. Wiviott, Joseph M. Massaro, Laura Mauri, P. Gabriel Steg, Donald E. Cutlip
Publikováno v:
Journal of the American College of Cardiology. 67:2492-2502
The DAPT (Dual Antiplatelet Therapy) study enrolled patients after coronary stenting. Patients randomized to continued thienopyridine and aspirin after 12 months had lower ischemic risk but higher bleeding risk than those treated with placebo and asp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3fbd215902226e39d4f0977ce77d710
https://doi.org/10.1016/j.jacc.2016.03.485
https://doi.org/10.1016/j.jacc.2016.03.485
Autor:
Precise-Dapt Study Investigators, David van Klaveren, Francesco Costa, Marco Valgimigli, Ewout W. Steyerberg
Publikováno v:
Journal of the American College of Cardiology. 74:162-163
We welcome the comments by Dr. Montalto and colleagues regarding our recent paper in the Journal [(1)][1], suggesting that PRECISE-DAPT (Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abbf579e0f326a11f15308ae2ce2e5ae
https://doi.org/10.1016/j.jacc.2019.05.005
https://doi.org/10.1016/j.jacc.2019.05.005
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jaroslaw Trebacz, Stephan Windecker, Donald E. Cutlip, Harald Darius, John A. Ormiston, Robert W. Yeh, Dapt Study Investigators, Priscilla Driscoll-Shempp, Dean J. Kereiakes, David P. Lee, David E. Kandzari, Laura Mauri, Kirk N. Garratt, Joseph M. Massaro, Ian T Meredith, Daniel I. Simon, P. Gabriel Steg, Jean-François Tanguay, Adrian Corneliu Iancu, Anthony H. Gershlick
Publikováno v:
JACC: Cardiovascular Interventions. 8(12):1552-1562
Objectives This study sought to compare rates of stent thrombosis and major adverse cardiac and cerebrovascular events (MACCE) (composite of death, myocardial infarction, or stroke) after coronary stenting with drug-eluting stents (DES) versus bare-m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135edc376706741b3d7fd8b6944bf945
Autor:
Philippe Gabriel Steg, Donald E. Cutlip, Stephen D. Wiviott, Stephan Windecker, Robert W. Yeh, Michael J. Rinaldi, Adrian C. Iancu, Dapt Study Investigators, Dean J. Kereiakes, Jean-François Tanguay, David J. Cohen, Alice K. Jacobs, Anthony H. Gershlick, Joseph M. Massaro, Laura Mauri
Publikováno v:
Journal of the American College of Cardiology. 65:2211-2221
BACKGROUND The benefits and risks of prolonged dual antiplatelet therapy may be different for patients with acute myocardial infarction (MI) compared with more stable presentations. OBJECTIVES This study sought to assess the benefits and risks of 30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab53f854bf0e872062349313549bd79
https://doi.org/10.1016/j.jacc.2015.03.003
https://doi.org/10.1016/j.jacc.2015.03.003
Autor:
Joseph M. Massaro, Kevin Croce, Dapt Study Investigators, Dean J. Kereiakes, Donald E. Cutlip, P. Gabriel Steg, Robert W. Yeh, Laura Mauri
Publikováno v:
J Am Coll Cardiol
BACKGROUND: Subjects undergoing coronary stenting with complex lesion anatomy may experience different risks and benefits with prolonged dual antiplatelet therapy. OBJECTIVE: The authors assessed the effect of 30 versus 12 months of dual antiplatelet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::671ff95761eed28f39354634e80e9604
https://pubmed.ncbi.nlm.nih.gov/29519361
https://pubmed.ncbi.nlm.nih.gov/29519361